Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 4Phase 2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 522Specimen Handling 383Carboplatin 375Magnetic Resonance Spectroscopy 338Cisplatin 331Nivolumab 308Cyclophosphamide 299Radiotherapy 256Paclitaxel 256Gemcitabine 236Biopsy 235Bevacizumab 215Dexamethasone 170durvalumab 167Oxaliplatin 163Capecitabine 159Rituximab 156Fluorouracil 149venetoclax 147Docetaxel 147Etoposide 142Drug Therapy 141atezolizumab 140Doxorubicin 134Ipilimumab 130Prednisone 120Radiosurgery 119Lenalidomide 119Leucovorin 113fludarabine 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ketoconazole × 1 year × Clear all
NCT00859781 2026-04-08

177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer

Weill Medical College of Cornell University

Phase 2 Active not recruiting
55 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡